Niquitin Mint (Nicotine Resinate)

Nicotine resinate acts as an agonist at nicotinic acetylcholine receptors in the oral mucosa. By stimulating these receptors, it delivers nicotine to the bloodstream, reproducing many of the central effects of smoked nicotine and thereby reducing the intensity of withdrawal symptoms and cravings.

The appropriate dose of Niquitin Mint is determined by a qualified healthcare professional based on the individual’s smoking history, level of dependence, and overall health. Prescribers set the regimen, and patients should follow the specific instructions provided by their clinician.

Safety data for nicotine resinate in pregnancy and lactation are limited. The product is classified as having an unknown pregnancy category, so it should only be used if the potential benefits outweigh the possible risks, and after consultation with a healthcare provider.

To order Niquitin Mint, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Niquitin Mint delivers nicotine via the oral mucosa, offering rapid absorption similar to lozenges or gum. Compared with transdermal patches, it provides quicker onset but shorter duration of action. It is an OTC option that avoids the need for prescription and can be used as part of a step‑down cessation plan.

Store Niquitin Mint at temperatures below 25 °C, in its original packaging, protected from moisture and direct heat. Keep the product out of reach of children and avoid exposure to excessive humidity, which could affect tablet integrity and nicotine content.

Niquitin Mint is placed in the mouth and allowed to dissolve slowly against the oral mucosa. The user should avoid chewing or swallowing the product whole, allowing the nicotine to be absorbed through the mucosal lining for optimal efficacy.

Serious risks include allergic reactions such as rash, swelling, or anaphylaxis, and cardiovascular events like increased heart rate, hypertension, or arrhythmias. Users should seek immediate medical attention if they experience any signs of a severe allergic response or cardiovascular distress.

Niquitin Mint should not be used by individuals under 18 years of age, by those with known hypersensitivity to nicotine resinate or any excipients, and by patients with uncontrolled cardiovascular disease unless advised otherwise by a healthcare professional.